Reardon Andrew
SEC insider (Form 3/4/5 filer). CIK 0001950232. CLO & Secretary at LIGAND PHARMACEUTICALS INC (LGND). 91 reported Form 4/5 transactions since Sep 2024; latest on Oct 2, 2026. Located in JUPITER, FL.
Companies Reardon Andrew has filed insider reports for
- LIGAND PHARMACEUTICALS INC (LGND): Officer, CLO & Secretary
Reardon Andrew
CIK: 0001950232
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LIGAND PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (91 total)
- Oct 2, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect1.5K shares at avg. $304.52$467K - Oct 2, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect2K shares at avg. $303.54$600K - Oct 2, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect17 shares at avg. $307.74$5K - Oct 2, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect235 shares at avg. $307.19$72K - Oct 2, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect404 shares at avg. $306.18$124K - Oct 2, 2026LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect340 shares at avg. $52.27$18K - Oct 2, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect833 shares at avg. $302.51$252K - Sep 3, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect1.8K shares at avg. $285.17$513K - Sep 3, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect300 shares at avg. $283.99$85K - Sep 3, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect2.1K shares at avg. $286.36$606K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | Sale | 1,535 | $304.52 | $467,431 | Direct |
| Oct 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | Sale | 1,976 | $303.54 | $599,804 | Direct |
| Oct 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | Sale | 17 | $307.74 | $5,232 | Direct |
| Oct 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | Sale | 235 | $307.19 | $72,190 | Direct |
| Oct 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | Sale | 404 | $306.18 | $123,698 | Direct |
| Oct 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 340 | $52.27 | $17,772 | Direct |
| Oct 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | Sale | 833 | $302.51 | $251,991 | Direct |
| Sep 3, 2026 | LGND LIGAND PHARMACEUTICALS INC | Sale | 1,800 | $285.17 | $513,301 | Direct |
| Sep 3, 2026 | LGND LIGAND PHARMACEUTICALS INC | Sale | 300 | $283.99 | $85,196 | Direct |
| Sep 3, 2026 | LGND LIGAND PHARMACEUTICALS INC | Sale | 2,115 | $286.36 | $605,649 | Direct |
1-10 of 91 transactions